With precision, purity, and scientific integrity at the core of our operations, BioGenix Peptides is dedicated to supporting responsible exploration and discovery
3 min read The GLP-1 landscape changed on 1 April 2026, when the FDA approved Eli Lilly's orforglipron under the brand name Foundayo as the first non-peptide, small-molecule GLP-1 receptor agonist (GLP-1RA) anywhere in the world
Lillys phase 2 retatrutide trial achieved up to 17.5% mean weight reduction at 24 weeks
When you require antibiotics whilst taking Saxenda, inform your GP, practice nurse, or prescribing clinician about your current use of liraglutide, including your current dose and how long you have been taking it
Due to an aging population and unhealthy lifestyle, the prevalence of type 2 diabetes is expected to increase steadily over the next few years
They are intentionally started at a low dose to support comfort and safety